Literature DB >> 21679109

Back to the future in bladder cancer research.

Antonia Vlahou.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21679109     DOI： 10.1586/epr.11.28

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN： 1478-9450            Impact factor:   3.940


× No keyword cloud information.
  4 in total

1.  Expression of cyclin D1 and cyclin E in urothelial bladder carcinoma detected in tissue chips using a quantum dot immunofluorescence technique.

Authors:  Guang Shan; Tian Tang
Journal:  Oncol Lett       Date:  2015-06-30       Impact factor: 2.967

Review 2.  Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions.

Authors:  Maria Frantzi; Antonia Vlahou
Journal:  Bladder Cancer       Date:  2017-01-27

Review 3.  Promise and Implementation of Proteomic Prostate Cancer Biomarkers.

Authors:  Agnieszka Latosinska; Maria Frantzi; Axel S Merseburger; Harald Mischak
Journal:  Diagnostics (Basel)       Date:  2018-08-29

Review 4.  Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease.

Authors:  Michelle J Pena; Harald Mischak; Hiddo J L Heerspink
Journal:  Diabetologia       Date:  2016-06-25       Impact factor: 10.122
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.